Keywords: Teva, Coppaxone, Generics (UK), Mylan, Patent ruling, UK, Multiple sclerosis

Teva gets favorable UK Copaxone patent ruling

Article | 12 July 2012

Print This

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA) says that the UK High Court of Justice issued a decision in favor of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in